Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity

Abstract

We have recently derived a series of cloned cell lines1 displaying natural killer (NK) cell-like activity from normal human fetal blood (25 weeks)2. The lines were obtained after repeated stimulation of mononuclear cells with allogeneic Epstein–Barr virus (EBV)-transformed B lymphocytes and are interleukin-2 (IL-2) dependent. Initial characterization of the clones has been reported previously1. Certain of these clones have been found to have unusual surface characteristics, namely, they are recognized by several well-defined anti-T3 antibodies, but do not react with WT31 (ref. 3), which is thought to recognise an invariant epitope of the human (Ti-αβ) structure4,5. Transcription of the genes encoding the α- and β-chains of the T-cell receptor was assessed in two of these clones (F6A4 and F6C7). Ti-β genes were found to be expressed, whereas α messenger RNA was not detected in Northern blot analysis. These data strongly suggest that these cells do not produce a stoichiometric T3/Ti-αβ receptor complex. However, experiments performed with a monoclonal antibody (anti-NKFi) developed against F6C7 cells demonstrated the existence of a unique clonotypic structure [relative molecular mass (Mr) 85,000 (85K)] which is surface-associated with T3 proteins. Furthermore, both anti-T3 and anti-NKFi were found to block cytotoxic effector function. Together, the results support the view that T3 proteins are involved in non-major histocompatibility complex (MHC)-restricted cytotoxic reactions mediated by certain circulating fetal lymphocytes which are likely to use a clonotypic structure distinct from both the ‘first’ (αβ)4 and the putative ‘second’ (γδ)4 T-cell receptor to recognize their target. The present studies were designed to characterize this structure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Nowill, A. et al. J. exp. Med. 163, 1601–1606 (1986).

    Article  CAS  PubMed  Google Scholar 

  2. Desmonts, G. et al. Lancet i, 500–504 (1985).

    Article  Google Scholar 

  3. Tax, W. et al. Nature 304, 445–447 (1983).

    Article  ADS  CAS  PubMed  Google Scholar 

  4. Meuer, S. C. et al. Nature 303, 808–812 (1983).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Spits, H. et al. J. Immun. 135, 1922–1926 (1985).

    CAS  PubMed  Google Scholar 

  6. Brenner, M. B. et al. Nature 322, 145–149 (1986).

    Article  ADS  CAS  PubMed  Google Scholar 

  7. Brenner, M. B., Trowbridge, I. S. & Strominger, J. L. Cell 40, 183–190 (1985).

    Article  CAS  PubMed  Google Scholar 

  8. Hercend, T. et al. J. exp. Med. 158, 1547–1553 (1983).

    Article  CAS  PubMed  Google Scholar 

  9. Ritz, J. et al. Science 228, 1540–1544 (1985).

    Article  ADS  CAS  PubMed  Google Scholar 

  10. Bank, I. et al. Nature 322, 179–181 (1986).

    Article  ADS  CAS  PubMed  Google Scholar 

  11. Hercend, T. et al. J. clin. Invest. 75, 932–943 (1985).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moingeon, P., Ythier, A., Goubin, G. et al. A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature 323, 638–640 (1986). https://doi.org/10.1038/323638a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/323638a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing